Navigation Links
Drug to Lower Cholesterol Underused

Despite the health benefits of drugs that lower cholesterol levels, research shows they remain underused.//

Lipid-lowering drugs can be started when a patient is in the hospital or at a follow-up appointment with a doctor. Researchers from Cleveland Clinic Foundation looked at the relationship between when lipid-lowering therapy is started during a hospital stay vs. in an outpatient setting and its long-term use.

For the study, researchers used information from patients from 69 centers in the United States and Canada. The patients were all part of a previous study. Researchers found 175 patients were all discharged taking cholesterol-lowering therapy and 1,951 were discharged without the therapy. Researchers then looked at who was put on the therapy and how long they adhered to the drug regimen.

After six months, 77 percent of the patients who started taking the drugs before they left the hospital continued taking the medicine compared to 25 percent of those who started the therapy after leaving the hospital. Researchers say they found that initiation of lipid lowering agents before discharge was the most important independent predictor of their use at follow-up and patients in whom lipid-lowering therapy was initiated before discharge were nearly three times as likely to be taking these agents six months later.

Researchers say more studies looking at other factors that can influence the long-term use of these drugs need to be done.


'"/>




Page: 1

Related medicine news :

1. Simvastatin Plus Niacin May Lower Heart Risks
2. Ritalin May Lower Cocaine Abuse
3. Eating More Often May Help Lower Cholesterol
4. Lower surgical volume linked to higher death rate
5. Lowering blood pressure beneficial for PAD patients
6. Lower chance of bone fracture with Vitamin D supplementation
7. Tea Pill Lowers Cholesterol
8. Aspirin Lowers Leukemia Risk
9. Almonds Help Lower Cholesterol
10. Lowering Risk of Breast Cancer Recurrence
11. Multi-Drug Therapy Effective in Lowering Blood Pressure
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... Milford, NJ (PRWEB) , ... October 13, 2017 , ... ... weekend at scenic Alexandria Park in Milford, NJ. This free event, sponsored by ... and physical activity. The fun run is geared towards children of all ages; ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
Breaking Medicine Technology: